Structure |
Chemical Name |
CAS |
MF |
|
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide |
835621-11-9 |
C21H15ClF4N4O4 |
|
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-(1-ethylpropyl)-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]Methyl]-1-(1H-1,2,4-triazol-1-yl)- |
161532-65-6 |
C37H42F2N8O3 |
|
1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one |
186521-85-7 |
C15H19ClO |
|
NSC 351869 |
31350-27-3 |
C14H14N2O4 |
|
4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxybenzamide |
176849-91-5 |
C15H22IN3O2 |
|
N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride |
63434-11-7 |
C25H39ClN2O4 |
|
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol |
915095-96-4 |
C24H29ClO8 |
|
Doxorubicin Imp B HBr salt |
148218-14-8 |
C29H35Br2NO11 |
|
(R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate |
126610-77-3 |
C20H25NO5S |
|
(2R,3R,4R,5S)-5-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-2-(2-hydroxyethyl)tetrahydrofuran-2,3,4-triol |
|
C23H27ClO7 |
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
|
Olaparib iMpurity |
|
|
|
(2S,3R,4R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((S)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol |
|
C21H25ClO6 |
|
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl) butanoate .(R)-2-hydroxy-2-phenylacetate |
1253055-94-5 |
C19H20F3NO5 |
|
Olaparib iMpurity A |
|
|
|
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
|
Posaconazole iMpurity 5 |
|
|
|
Topiroxostat Impurity 5 |
1199273-82-9 |
C14H7N7 |
|
N-Ethoxycarbonyl Ciprofloxacin |
93594-29-7 |
C20H22FN3O5 |
|
Norepinephrine Tartrate Impurity G |
13062-58-3 |
C22H21NO3 |
|
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
|
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
|
1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone |
98414-56-3 |
C7H8N6O |
|
2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol |
1354945-69-9 |
C17H26N6O4S |
|
Vonoprazan Impurity E |
|
|
|
Disalicylimide |
1972-71-0 |
C14H11NO4 |
|
Atomoxetine impurity D |
1643684-02-9 |
C17H21NO |
|
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
|
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
|
Parecoxib Impurity M |
|
|
|
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
|
Linagliptin Impurity O |
|
|
|
Linagliptin Impurity T |
|
|
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
|
Etoricoxib Impurity 16 |
|
|
|
Ibrutinib Impurity 2 |
|
|
|
Mirabegron Impurity 14 |
|
|
|
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
|
Atenolol EP Impurity |
|
C14H22N2O3 |
|
Cinacalcet Impurity 20 |
|
|
|
Dapagliflozin Impurity 11 |
|
|
|
Dasatinib Impurity C |
|
|
|
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
|
Flucloxacillin Impurity |
|
|
|
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
|
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
|
Clopidogrel impurity reference substance |
|
C15H14ClNO2S |
|
Vildagliptin Impurity |
|
|
|
Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ) |
|
|
|
cefditoren E-isomer(C=C) |
|
|
|
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
|
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
|
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
|
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
|
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
|
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
|
Moxifloxacin Related Impurity 3 |
|
|
|
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
|
Levofloxacin N-Oxide |
117678-37-2 |
C18H20FN3O5 |
|
Oseltamivir EP Impurity A |
1391047-93-0 |
C14H24N2O4 |
|
Quetiapine EP Impurity N |
1800291-86-4 |
C29H41N5O3S |
|
Ceftazidime Impurity |
|
|
|
Chlorhexidine Digluconate Impurity N |
152504-10-4 |
C15H25ClN8 |
|
S-Azetidin-3-yl ethanethioate HCl |
886615-18-5 |
C5H9NOS |
|
Olaparib Impurity C |
|
|
|
Olaparib Impurity F |
|
|
|
Dapoxetine Impurity 4 |
|
|
|
Glycopyrrolate impurity 3 |
|
|
|
Lamotrigine impurity B |
|
|
|
Ramosetron Impurity 3 |
|
|
|
Loratadine Impurity 1 |
|
C22H23ClN2O2 |
|
Metoprolol IMpurity 6 |
|
C15H25NO3 |
|
Pitavastatin Impurity 5 |
|
|
|
Prasugrel Impurity C |
|
|
|
Trifluridine Impurity 2 |
|
|
|
Cefazolin Impurity 4 |
|
|
|
Vonoprazan Impurity 3 |
|
|
|
Cinacalcene Impurity I |
|
|
|
Valsartan Impurity 2 |
|
C24H29N5O3 |
|
Istradefylline Impurity 2 |
|
|
|
Etoricoxib Impurity 3 |
|
|
|
Topiroxostat Imp.C |
|
|
|
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-08-7 |
C24H21ClFNO3 |
|
Rabeprazole Impurity 2 |
1163685-31-1 |
C11H15NO4 |
|
Regorafenib Impurity 8 |
|
|
|
Flomoxef Impurity 5 |
134237-56-2 |
C25H23ClF2N2O6S |
|
Ranitidine impurity |
94167-82-5 |
C10H18N2O |
|
Pitavastatin Impurity 59 |
|
|
|
Lenvatinib Impurity 42 |
|
|
|
Tazobactam Impurity 8 |
|
|
|
Prednicarbate Impurity B |
|
|
|
Doxofylline Impurity 13 |
|
|
|
Canagliflozin Impurity 60 |
|
|
|
Canagliflozin Impurity 65 |
|
|
|
Rosuvastatin Impurity 75 |
|
|
|
Selexipag Impurity 6 |
|
|
|
Cabozantinib impurity N |
|
|
|
Barcitinib impurity-09 |
1187594-16-6 |
C14H13N7 |
|
Rotigotine Impurity 6 |
|
|
|
Olprinone Impurity 7 |
2236020-10-1 |
C9H10N2 |